Median Technologies

Pioneering innovative imaging services and Software as a Medical Device, Median Technologies harnesses cutting-edge AI to enhance the accuracy of early cancer diagnoses and cancer treatments. Median's offerings include iCRO, which provides medical image analysis and management in oncology trials, and eyonis™, an AI/ML tech-based suite of software as a medical device (SaMD) for the early diagnosis of lung and liver cancers. Median empowers biopharmaceutical entities and clinicians to advance patient care and expedite the development of novel therapies.